Federal Register / Vol. 74, No. 189 / Thursday, October 1, 2009 / Notices 50799 

(NIOSH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice as required 

by 42 CFR 83.12(e) of a decision to 

evaluate a petition to designate a class 

of employees for the Hanford site in 

Richland, Washington, to be included in 

the Special Exposure Cohort under the 

Energy Employees Occupational Illness 

Compensation Program Act of 2000. The 

initial proposed definition for the class 

being evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Hanford site. 

Location: Richland, Washington. 

Job Titles and/or Job Duties: All 

employees of the Department of Energy, 

its predecessor agencies, and its 

contractors and subcontractors. 

Period of Employment: October 1, 

1943 through June 30, 1972. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 

513–533–6800 (this is not a toll-free 

number). Information requests can also 

be submitted by e-mail to 

OCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. E9–23686 Filed 9–30–09; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10237 and CMS– 

10137] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the Agency’s function; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Medicare 

Advantage Applications-Part C ; Use: 

Under section 1851(a)(1) of the Social 

Security Act, every individual entitled 

to Medicare Part A and enrolled under 

Part B, except for most individuals with 

end-stage renal disease (ESRD), could 

elect to receive benefits either through 

the Original Medicare Program or an 

M+C plan, if one was offered where he 

or she lived. The Medicare Prescription 

Drug, Improvement, and Modernization 

Act of 2003 (MMA) Public Law 108–173 

was enacted on December 8, 2003. The 

MMA established the Medicare 

Prescription Drug Benefit Program (Part 

D) and made revisions to the provisions 

of Medicare Part C, governing what is 

now called the Medicare Advantage 

(MA) program (formerly 

Medicare+Choice). The MMA was 

amended on July 15, 2008 by the 

enactment of the Medicare 

Improvements for Patients and 

Providers Act of 2008 (MIPPA). 

Coverage for the prescription drug 

benefit is provided through contracted 

prescription drug plans or through 

Medicare Advantage (MA) plans that 

offer integrated prescription drug and 

health care coverage (MA–PD plans). 

Cost plans that are required under 

section 1876 of the Social Security Act, 

and Employer Group Waiver Plans 

(EGWP) may also provide a Part D 

benefit. Organizations wishing to 

provide services under the MA and 

MA–PD plans must complete an 

application, negotiate rates and receive 

final approval from CMS. Certain 

existing MA plans may also expand 

their contracted area by completing the 

Service Area Expansion (SAE) 

application. Health plans must meet 

regulatory requirements to enter into a 

contract with CMS in order to provide 

health benefits to Medicare 

beneficiaries. The revised MA 

applications are the collection 

receptacles required. Refer to the 

supporting document- High-Level 

Summary of All Part C Application 

Revisions- for a list of changes: Form 

Number: CMS–10237 (OMB#: 0938– 

0935); Frequency: Reporting—Yearly; 

Affected Public: Business or other forprofits and not-for-profit institutions; 

Number of Respondents: 291; Total 

Annual Responses: 291; Total Annual 

Hours: 9547. (For policy questions 

regarding this collection contact Letticia 

Ramsey at 410–786–5262. For all other 

issues call 410–786–1326.) 

2. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Application for 

Prescription Drug Plans (PDP); 

Application for Medicare Advantage 

Prescription Drug (MA–PD); 

Application for Cost Plans to Offer 

Qualified Prescription Drug Coverage; 

Application for Employer Group Waiver 

Plans to Offer Prescription Drug 

Coverage; Service Area Expansion 

Application for Prescription Drug 

Coverage; Use: The Medicare 

Prescription Drug Benefit program was 

established by section 101 of the 

Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003 (MMA) and is codified in section 

1860D of the Social Security Act (the 

Act). Section 101 of the MMA amended 

Title XVIII of the Social Security Act by 

redesignating Part D as Part E and 

inserting a new Part D, which 

establishes the voluntary Prescription 

Drug Benefit Program (‘‘Part D’’). The 

MMA was amended on July 15, 2008 by 

the enactment of the Medicare 

Improvements for Patients and 

Providers Act of 2008 (MIPPA). 

Coverage for the prescription drug 

benefit is provided through contracted 

prescription drug plans (PDPs) or 

through Medicare Advantage (MA) 

plans that offer integrated prescription 

drug and health care coverage (MA–PD 

plans). Cost Plans that are regulated 

under Section 1876 of the Social 

Security Act, and Employer Group 

Waiver Plans (EGWP) may also provide 

a Part D benefit. Organizations wishing 

to provide services under the 

Prescription Drug Benefit Program must 

complete an application, negotiate rates 

and receive final approval from CMS. 

Existing Part D sponsors may also 

expand their contracted service area by 

completing the Service Area Expansion 

(SAE) application. Refer to supporting 

document ‘‘Summary of Substantive 

and Technical Changes for All Part D 

Application Revisions from 2010 

Version of Part D application to 2011 

Draft Version’’: Form Number: CMS– 

10137 (OMB#: 0938–0936); Frequency: 

Reporting—Once; Affected Public: 

Business or other for-profits and Notfor-profit institutions; Number of 

Respondents: 453; Total Annual 

Responses: 453; Total Annual Hours: 


PWALKER on DSK8KYBLC1PROD with NOTICES
50800 Federal Register / Vol. 74, No. 189 / Thursday, October 1, 2009 / Notices 

11,919. (For policy questions regarding 

this collection contact Marla Rothouse 

at 410–786–8063. For all other issues 

call 410–786–1326.) 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS Web site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or 

E-mail your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

To be assured consideration, 

comments and recommendations for the 

proposed information collections must 

be received by the OMB desk officer at 

the address below, no later than 5 p.m. 

on November 2, 2009. 

OMB, Office of Information and 

Regulatory Affairs, 

Attention: CMS Desk Officer. 

Fax Number: (202) 395–6974. 

E-mail: 

OIRA_submission@omb.eop.gov. 

Dated: September 24, 2009. 

Michelle Shortt, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. E9–23707 Filed 9–30–09; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–09–08AU] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Assessing Problem Areas in Referrals 

for Chronic Hematologic Malignancies 

and Developing Interventions to 

Address Them—New—Division of 

Cancer Prevention and Control (DCPC), 

National Center for Chronic Disease 

Prevention and Health Promotion 

(NCCDPHP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

Despite the advent of new diagnostics 

and therapeutics for patients with 

chronic hematological malignancies, 

data from the United States, Europe and 

Canada allude to a problem of timely 

referral and diagnosis for patients with 

cancer. Improving the timeliness of care 

and referral to appropriate specialists 

are key health care quality objectives. 

CDC proposes to conduct a one-time 

study to collect qualitative and 

quantitative information on optimal and 

suboptimal referral patterns for patients 

with confirmed or suspected chronic 

hematologic malignancies. Information 

will be collected to identify specific 

factors related to delays in diagnosis 

and/or referral to appropriate medical 

specialists. Information will be collected 

through in-depth interviews with 

hematologic cancer patients, in-depth 

interviews and focus groups with 

primary care providers, interviews with 

specialists in hematology and oncology, 

and a one-time postal survey to a 

sample of primary care providers (PCP). 

The PCP survey may be completed in 

paper form or via the Web. 

The ultimate goal is to develop tools 

that will improve the awareness, 

diagnosis, and referral of persons with 

chronic hematological cancers by 

primary care providers. 

There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

198. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name No. of 

respondents 

No. of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Community Hematologists/Oncologists .......... Community Hematologists and Oncologists 

Interview Phone Recruitment Script.

100 1 2/60 

Community Hematologists and Oncologists 

Interview Guide.

18 1 1.5 

Patients ........................................................... Patient Interview Phone Recruitment Script .. 50 1 2/60 

Patient Interview Guide .................................. 18 1 1.5 

Primary Care Providers (PCP) ....................... PCP Survey Cover Letter ............................... 250 1 2/60 

PCP Survey .................................................... 150 1 20/60 

PCP Opt-Out Card ......................................... 100 1 2/60 

PCP Survey Reminder Letter ......................... 200 1 2/60 

PCP Interview Phone Recruitment Script ...... 100 1 3/60 

PCP Interview Guide ...................................... 18 1 1.5 

PCP Focus Group Phone Recruitment Script 50 1 3/60 

PCP Focus Group Guide ............................... 18 1 2 


PWALKER on DSK8KYBLC1PROD with NOTICES